Medicis is a professional preclinical comprehensive biomedical research and development service CRO, which provides global pharmaceutical enterprises and scientific research institutions with all-round one-stop new drug research and development services that meet the domestic and international reporting standards. Company services cover the whole process of preclinical drug research, including drug discovery, pharmaceutical research and preclinical research.
Drug discovery research and development services include protein target verification, structural biology, chemical synthesis, compound activity screening and optimization; Pharmaceutical research includes raw materials and preparation technology research, quality standards and stability research; Preclinical studies include pharmacodynamics, pharmacokinetics, toxicological safety evaluation, etc.
The company pays attention to the innovation and development needs of the global pharmaceutical industry, based on the key links of innovative drug research and development, and relies on the accumulated experience in serving the biomedical industry at home and abroad to build a comprehensive technology platform covering key technologies of drug discovery, drug research and preclinical research, so as to provide comprehensive preclinical research and development services for the global biomedical industry.
Introduction to CRO
The full name of CRO is: contract research institution, which is also called clinical research institution. Simply put, it is an institution entrusted by pharmaceutical companies or biotechnology companies to provide professional services such as non-clinical and clinical trials, data analysis and regulatory consultation required for new drug research and development.
CRO is a professional division of labor system, which has been implemented abroad for a long time. Providing all services from drug research and development to market for pharmaceutical, biotechnology, medical device industries and research institutions can avoid all units from investing too much manpower and equipment in a certain stage of research and development, and at the same time, it can track and analyze a large number of clinical and preclinical trial data, saving the time of clinical trials. At present, there are more than 1000 Red Cross Societies in the world.
Introduction of official website-Medici Biomedical Co., Ltd.